CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Metaplasia

A condition in which there is a change of one adult cell type to another similar adult cell type.

Subtype terms (1)

More specific conditions that are subtypes of Metaplasia in the MeSH hierarchy.

  • Neovascularization, Pathologic

    24 drugs (11 approved, 13 experimental)

Drugs by status

Phase 1 trials (2)

  • trametinib
  • erlotinib

Organizations

Organization Involved with Phase 4 Indications (1)

  • Shandong University

Organization Involved with Phase 3 Indications (7)

  • AstraZeneca
  • National Institutes of Health (NIH)
  • University of London
  • Rutgers University
  • University of Medicine and Dentistry of New Jersey
  • Tianjin Medical University
  • University of Oxford

Organization Involved with Phase 2 Indications (16)

  • Takeda
  • Celgene
  • Bristol-Myers Squibb
  • Merck
  • Novartis
  • Ariad Pharmaceuticals
  • Cancer Prevention Pharmaceuticals, Inc.
  • National Cancer Institute (NCI)
  • Harvard University
  • Katholieke Universiteit Leuven
  • Ohio State University
  • Southwest Oncology Group
  • Mayo Clinic
  • Vanderbilt University
  • University of Texas at Houston
  • Gemin X

Organization Involved with Phase 1 Indications (7)

  • Millennium Pharmaceuticals
  • CASI Pharmaceuticals, Inc.
  • Main Line Health
  • Northwestern University
  • University of Toronto
  • Washington University in St. Louis
  • Sharpe-Strumia Research Foundation

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.